Vitamin B2 (riboflavin)

Updated June 3, 2026

Riboflavin becomes two of the most important coenzymes in mammalian metabolism, and that is what makes it useful far beyond the modest RDA. The body phosphorylates B2 into flavin mononucleotide and flavin adenine dinucleotide, and those two molecules do concrete biochemical work every second you are alive. FAD sits at the heart of Complex I and Complex II in the mitochondrial electron transport chain, which is where ATP actually comes from. Complex I uses FMN as its electron-accepting prosthetic group, pulling electrons off NADH and starting the proton gradient that drives ATP synthase. Complex II uses covalently bound FAD to feed succinate-derived electrons into the same chain. Without enough flavin cofactor, both entry points to oxidative phosphorylation slow down. FAD is also the cofactor for fatty acid beta-oxidation (acyl-CoA dehydrogenase is FAD-dependent), for glutathione reductase, and for a long list of dehydrogenases that move electrons around the cell. When people say B2 supports energy and antioxidant function, the mechanism is established, not vague.

The antioxidant angle is worth slowing down on. Glutathione reductase takes oxidized glutathione disulfide (GSSG) and uses NADPH to regenerate reduced glutathione (GSH), the cell's main intracellular antioxidant. The enzyme cannot do its job without FAD. That puts riboflavin status upstream of the entire glutathione recycling cycle, and by extension upstream of the vitamin C and vitamin E recycling that depends on GSH. Low FAD, sluggish GSH regeneration, more oxidative load. The same logic extends to flavin-containing monooxygenases (FMOs), which handle phase I detoxification of nitrogen- and sulfur-containing xenobiotics. Quiet plumbing.

The bright yellow urine after a B-complex tablet is part of that story. The body absorbs what it needs, converts most of it into FMN and FAD, and excretes the surplus through the kidneys. That excess is harmless. It is also the easiest visible confirmation that any B-complex actually contains a meaningful dose of B2.

Migraine prevention is where B2 has earned real clinical respect. The headline trial is Schoenen 1998, in Neurology: 400 mg of riboflavin daily reduced migraine attack frequency by about half over three months in a randomized controlled study. The effect builds slowly, usually over six to twelve weeks. Follow-up trials and a 2017 meta-analysis have backed the result up. The American Headache Society lists riboflavin among the supplements with level B evidence for migraine prevention, which is rare territory for a vitamin. The mechanistic story fits the timing. Migraine brains show measurable mitochondrial dysfunction and lower ATP reserve between attacks. Saturating the flavin cofactor pool at 400 mg gives Complex I and Complex II more substrate, slowly restoring cortical energy reserve. That is consistent with why coenzyme Q10 and magnesium, the other two evidence-backed prophylactics, also act on mitochondrial energetics. The dose is roughly three hundred times the RDA, and the safety record is clean even at that level.

The MTHFR connection is one of the cleaner examples of a B vitamin moving a downstream pathway in a defined subgroup. The methylenetetrahydrofolate reductase enzyme uses FAD as a cofactor, so riboflavin status directly affects how well someone metabolizes folate, which in turn affects how efficiently homocysteine gets remethylated back to methionine. People with the common C677T MTHFR polymorphism have an enzyme that destabilizes when FAD is low. A 2007 trial by McNulty and colleagues showed that supplemental riboflavin at 1.6 mg per day lowered blood pressure in hypertensive adults carrying the variant, presumably by restoring enzyme function. Follow-up work has tied the effect to better folate cycling and lower homocysteine, which is the link to endothelial function. Quiet, targeted, mechanistically clean.

RDA numbers are modest. The NIH Office of Dietary Supplements sets the adult RDA at 1.1 mg per day for women and 1.3 mg for men, with no established tolerable upper limit because excess riboflavin is water-soluble and excreted rapidly. Deficiency is uncommon in countries with fortified grain, but it does occur in chronic alcohol use, in some inflammatory bowel disease, in older adults with poor intake, and in long-term use of certain medications. The clinical picture (ariboflavinosis) is sore throat, cracks at the corners of the mouth, inflamed tongue, mild dermatitis around the nose, and sometimes photophobia.

On forms. Plain riboflavin is the standard, cheap, and effective choice for almost everyone. The body phosphorylates it to FMN in the small intestine and the liver, then conjugates FMN with AMP to make FAD. Riboflavin 5'-phosphate (R5P, sometimes labeled as "activated B2") skips the first phosphorylation step. People with poor phosphorylation due to magnesium deficiency, thyroid dysfunction, or alcohol use convert plain riboflavin to FMN sluggishly, and R5P bypasses that bottleneck. The phosphorylation step itself is ATP-dependent and magnesium-dependent, which is why these conversion issues cluster. The mechanism is real. The clinical advantage in healthy adults is small, so R5P earns its higher cost mainly when you have known conversion issues.

Compared to the other B vitamins, riboflavin is unusually safe and unusually quiet. B6 has a tolerable upper limit because of peripheral neuropathy at chronic high doses. B3 (niacin) causes flushing at modest doses, though it carries its own NAD-pathway story that B2 does not. B12 carries injection-only complications. Folate without enough B2 cannot finish its job through MTHFR. B2 just does its job, brightens your urine, and exits.

A few interactions are worth knowing. Tricyclic antidepressants and some other anticholinergics can mildly reduce riboflavin absorption. Tetracycline antibiotics interfere with B2 metabolism. Phenobarbital and certain other anticonvulsants can increase riboflavin clearance over the long term. None of these is acute. They matter for chronic users on the affected medications.

None of this is medical advice. If you take anticonvulsants, tricyclics, are pregnant, are nursing, or are using high-dose riboflavin (400 mg per day) for migraine prevention as a self-experiment, run it past a clinician who can confirm it does not conflict with anything else you take.

The summary worth keeping. Riboflavin is the unsexy B vitamin that sits behind two of the workhorse coenzymes in cellular metabolism. The RDA covers basic needs. The 400 mg migraine prevention dose has real trial support and is one of the few supplements with American Headache Society backing, and the most plausible mechanism is restored mitochondrial cortical ATP. The FAD-MTHFR link makes B2 status quietly important for anyone with that genetic variant, elevated homocysteine, or blood pressure that does not respond to the usual levers. The FAD-glutathione reductase link makes it upstream of the cell's main antioxidant cycle. Plain riboflavin works for almost everyone. R5P earns its higher cost in specific contexts.